@article{watson-skaggs_gieger_yoshikawa_nolan_2022, title={Endocrine response and outcome in 14 cats with insulin resistance and acromegaly treated with stereotactic radiosurgery (17 Gy)}, volume={83}, ISSN={["1943-5681"]}, DOI={10.2460/ajvr.21.08.0122}, abstractNote={Abstract}, number={1}, journal={AMERICAN JOURNAL OF VETERINARY RESEARCH}, author={Watson-Skaggs, Maegan L. and Gieger, Tracy L. and Yoshikawa, Hiroto and Nolan, Michael W.}, year={2022}, month={Jan}, pages={64–71} } @article{nolan_berman_watson-skaggs_quinn_marcus_russell_yoshikawa_olby_gieger_2022, title={Stereotactic radiotherapy (10 Gy X 3) for canine nonlymphomatous intranasal tumors is associated with prolonged survival and minimal risk of severe radiotoxicity}, volume={260}, ISSN={["1943-569X"]}, DOI={10.2460/javma.22.03.0141}, abstractNote={Abstract}, number={12}, journal={JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION}, author={Nolan, Michael W. and Berman, Alyssa R. and Watson-Skaggs, Maegan L. and Quinn, Claire N. and Marcus, Karen L. and Russell, Katharine and Yoshikawa, Hiroto and Olby, Natasha J. and Gieger, Tracy L.}, year={2022}, month={Sep}, pages={1496–1506} } @article{yoshikawa_gieger_saba_fredrickson_kubicek_haney_ruslander_kelsey_mcentee_nolan_2021, title={Retrospective evaluation of intranasal carcinomas in cats treated with external-beam radiotherapy: 42 cases}, volume={35}, ISSN={["1939-1676"]}, DOI={10.1111/jvim.16098}, abstractNote={Abstract}, number={2}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, author={Yoshikawa, Hiroto and Gieger, Tracy L. and Saba, Corey F. and Fredrickson, Kirsha and Kubicek, Lyndsay and Haney, Siobhan and Ruslander, David and Kelsey, Krista L. and McEntee, Margaret C. and Nolan, Michael W.}, year={2021}, month={Mar}, pages={1018–1030} } @article{rickard_yoshikawa_palmer_liu_dewhirst_nolan_zhang_2020, title={Cherenkov emissions for studying tumor changes during radiation therapy: An exploratory study in domesticated dogs with naturally-occurring cancer}, volume={15}, ISSN={["1932-6203"]}, DOI={10.1371/journal.pone.0238106}, abstractNote={Purpose Real-time monitoring of physiological changes of tumor tissue during radiation therapy (RT) could improve therapeutic efficacy and predict therapeutic outcomes. Cherenkov radiation is a normal byproduct of radiation deposited in tissue. Previous studies in rat tumors have confirmed a correlation between Cherenkov emission spectra and optical measurements of blood-oxygen saturation based on the tissue absorption coefficients. The purpose of this study is to determine if it is feasible to image Cherenkov emissions during radiation therapy in larger human-sized tumors of pet dogs with cancer. We also wished to validate the prior work in rats, to determine if Cherenkov emissions have the potential to act an indicator of blood-oxygen saturation or water-content changes in the tumor tissue–both of which have been correlated with patient prognosis. Methods A DoseOptics camera, built to image the low-intensity emission of Cherenkov radiation, was used to measure Cherenkov intensities in a cohort of cancer-bearing pet dogs during clinical irradiation. Tumor type and location varied, as did the radiation fractionation scheme and beam arrangement, each planned according to institutional standard-of-care. Unmodulated radiation was delivered using multiple 6 MV X-ray beams from a clinical linear accelerator. Each dog was treated with a minimum of 16 Gy total, in ≥3 fractions. Each fraction was split into at least three subfractions per gantry angle. During each subfraction, Cherenkov emissions were imaged. Results We documented significant intra-subfraction differences between the Cherenkov intensities for normal tissue, whole-tumor tissue, tissue at the edge of the tumor and tissue at the center of the tumor (p<0.05). Additionally, intra-subfraction changes suggest that Cherenkov emissions may have captured fluctuating absorption properties within the tumor. Conclusion Here we demonstrate that it is possible to obtain Cherenkov emissions from canine cancers within a fraction of radiotherapy. The entire optical spectrum was obtained which includes the window for imaging changes in water and hemoglobin saturation. This lends credence to the goal of using this method during radiotherapy in human patients and client-owned pets.}, number={8}, journal={PLOS ONE}, author={Rickard, Ashlyn G. and Yoshikawa, Hiroto and Palmer, Gregory M. and Liu, Harrison Q. and Dewhirst, Mark W. and Nolan, Michael W. and Zhang, Xiaofeng}, year={2020}, month={Aug} } @article{yoshikawa_nolan_2019, title={Changes in target volume during irradiation of canine intranasal tumors can significantly impact radiation dosimetry}, volume={60}, ISSN={["1740-8261"]}, DOI={10.1111/vru.12782}, abstractNote={Abstract}, number={5}, journal={VETERINARY RADIOLOGY & ULTRASOUND}, author={Yoshikawa, Hiroto and Nolan, Michael W.}, year={2019}, month={Sep}, pages={594–604} } @article{yoshikawa_sunada_hirakawa_fujimori_elmegerhi_leary_kato_2019, title={Radiobiological Characterization of Canine Malignant Melanoma Cell Lines with Different Types of Ionizing Radiation and Efficacy Evaluation with Cytotoxic Agents}, volume={20}, ISSN={["1422-0067"]}, DOI={10.3390/ijms20040841}, abstractNote={Canine malignant melanoma (CMM) is a locally and systemically aggressive cancer that shares many biological and clinical characteristics with human mucosal melanoma. Hypofractionated radiation protocols have been used to treat CMM but little is known about its radiation biology. This pilot study is designed to investigate response of CMM cell lines to various ionizing radiations and cytotoxic agents to better understand this canine cancer. Four CMM cell lines were evaluated by clonogenic survival assay under aerobic and hypoxic conditions and parameters such as alpha beta (α/β) ratio, oxygen enhancement ratio (OER), and relative biological effectiveness (RBE) were calculated after 137Cs, 6 megavoltage (MV) photon, or carbon ion irradiation. Six cytotoxic agents (cisplatin, camptothecin, mitomycin C, bleomycin, methtyl methanesulfonate and etoposide) were also assessed for their efficacy. Under aerobic condition with 6 MV photon, the α/β ratio of the four cell lines ranged from 0.3 to >100, indicating a wide variation of cellular sensitivity. The ratio increased under hypoxic condition compared to aerobic condition and this was more dramatic in 137Cs and 6 MV photon treatments. OER of carbon was lower than 137Cs at D10 in 3 of the 4 cell lines. The RBE values generally increased with the increase of LET. Different cell lines showed sensitivity/resistance to different cytotoxic agents. This study revealed that CMM has a wide range of radiosensitivity and that hypoxia can reduce it, indicating that widely used hypofractionated protocols may not be optimal for all CMM patients. Several cytotoxic agents that have never been clinically assessed can improve treatment outcome.}, number={4}, journal={INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES}, author={Yoshikawa, Hiroto and Sunada, Shigeaki and Hirakawa, Hirokazu and Fujimori, Akira and Elmegerhi, Suad and Leary, Del and Kato, Takamitsu A.}, year={2019}, month={Feb} } @article{sweet_nolan_yoshikawa_gieger_2019, title={Stereotactic radiation therapy for canine multilobular osteochondrosarcoma: Eight cases}, ISSN={1476-5810 1476-5829}, url={http://dx.doi.org/10.1111/vco.12481}, DOI={10.1111/vco.12481}, abstractNote={Abstract}, journal={Veterinary and Comparative Oncology}, publisher={Wiley}, author={Sweet, Katherine A. and Nolan, Michael W. and Yoshikawa, Hiroto and Gieger, Tracy L.}, year={2019}, month={Jun} } @article{yoshikawa_nolan_lewis_larue_2016, title={Retrospective evaluation of interfractional ureteral movement in dogs undergoing radiation therapy to elucidate appropriate setup margins}, volume={57}, ISSN={1058-8183}, url={http://dx.doi.org/10.1111/vru.12309}, DOI={10.1111/vru.12309}, abstractNote={Radiation‐induced ureteral damage can result in serious complications (i.e., hydronephrosis). Also, ureters can be included in planning target volume (PTV) such as ureteral invasion of urinary bladder carcinoma. Therefore, knowing the interfractional movement of the ureters is critical for creation of appropriate planning organs at risk (pOAR) and PTV. This retrospective and descriptive study of 17 dogs with genitourinary carcinomas that underwent intensity‐modulated, image‐guided radiation therapy (IM‐IGRT) was conducted to describe the movement and calculate suggested pOAR/PTV expansions at three locations (at the levels of third lumbar vertebra, immediately cranial to vesicoureteral junction [VUJ], and midway between those two) and from two perspectives: during a course of (1) IM‐IGRT, where position verification is performed using soft tissue registration when the dogs underwent clinical IM‐IGRT; (2) radiation therapy whereby position verification is performed using planar radiography with a corresponding bony registration. This registration was performed by fusing the radiation planning computed tomography (CT) and cone‐beam CTs using bony landmarks. With soft tissue registration, findings supported the use of larger pOAR expansion (0.7–1.8 cm) for the mid region of the ureters compared to the areas near VUJ (0.7–1.1 cm). With bony registration, findings supported the use of larger pOAR/PTV expansions (1.6–1.7 cm) for dorsal direction bilaterally at areas near VUJ compared to those with soft tissue registration (0.9–1.0 cm). The results of this study should help radiation oncologists use appropriate ureter expansions for specific patient orientations and positioning verification methods.}, number={2}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Yoshikawa, Hiroto and Nolan, Michael W. and Lewis, Dustin W. and Larue, Susan M.}, year={2016}, month={Mar}, pages={170–179} } @article{yoshikawa_roback_larue_nolan_2015, title={Dosimetric consequences of using contrast-enhanced computed tomographic images for intensity-modulated stereotactic body radiotherapy planning}, volume={56}, ISSN={1058-8183}, url={http://dx.doi.org/10.1111/vru.12281}, DOI={10.1111/vru.12281}, abstractNote={Potential benefits of planning radiation therapy on a contrast‐enhanced computed tomography scan (ceCT) should be weighed against the possibility that this practice may be associated with an inadvertent risk of overdosing nearby normal tissues. This study investigated the influence of ceCT on intensity‐modulated stereotactic body radiotherapy (IM‐SBRT) planning. Dogs with head and neck, pelvic, or appendicular tumors were included in this retrospective cross‐sectional study. All IM‐SBRT plans were constructed on a pre‐ or ceCT. Contours for tumor and organs at risk (OAR) were manually constructed and copied onto both CT's; IM‐SBRT plans were calculated on each CT in a manner that resulted in equal radiation fluence. The maximum and mean doses for OAR, and minimum, maximum, and mean doses for targets were compared. Data were collected from 40 dogs per anatomic site (head and neck, pelvis, and limbs). The average dose difference between minimum, maximum, and mean doses as calculated on pre‐ and ceCT plans for the gross tumor volume was less than 1% for all anatomic sites. Similarly, the differences between mean and maximum doses for OAR were less than 1%. The difference in dose distribution between plans made on CTs with and without contrast enhancement was tolerable at all treatment sites. Therefore, although caution would be recommended when planning IM‐SBRT for tumors near “reservoirs” for contrast media (such as the heart and urinary bladder), findings supported the use of ceCT with this dose calculation algorithm for both target delineation and IM‐SBRT treatment planning.}, number={6}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Yoshikawa, Hiroto and Roback, Donald M. and Larue, Susan M. and Nolan, Michael W.}, year={2015}, month={Aug}, pages={687–695} } @article{nolan_marolf_ehrhart_rao_kraft_engel_yoshikawa_golden_wasserman_larue_2015, title={Pudendal Nerve and Internal Pudendal Artery Damage May Contribute to Radiation-Induced Erectile Dysfunction}, volume={91}, ISSN={0360-3016}, url={http://dx.doi.org/10.1016/j.ijrobp.2014.12.025}, DOI={10.1016/j.ijrobp.2014.12.025}, abstractNote={

Purpose/Objectives

Erectile dysfunction is common after radiation therapy for prostate cancer; yet, the etiopathology of radiation-induced erectile dysfunction (RI-ED) remains poorly understood. A novel animal model was developed to study RI-ED, wherein stereotactic body radiation therapy (SBRT) was used to irradiate the prostate, neurovascular bundles (NVB), and penile bulb (PB) of dogs. The purpose was to describe vascular and neurogenic injuries after the irradiation of only the NVB or the PB, and after irradiation of all 3 sites (prostate, NVB, and PB) with varying doses of radiation.

Methods and Materials

Dogs were treated with 50, 40, or 30 Gy to the prostate, NVB, and PB, or 50 Gy to either the NVB or the PB, by 5-fraction SBRT. Electrophysiologic studies of the pudendal nerve and bulbospongiosus muscles and ultrasound studies of pelvic perfusion were performed before and after SBRT. The results of these bioassays were correlated with histopathologic changes.

Results

SBRT caused slowing of the systolic rise time, which corresponded to decreased arterial patency. Alterations in the response of the internal pudendal artery to vasoactive drugs were observed, wherein SBRT caused a paradoxical response to papaverine, slowing the systolic rise time after 40 and 50 Gy; these changes appeared to have some dose dependency. The neurofilament content of penile nerves was also decreased at high doses and was more profound when the PB was irradiated than when the NVB was irradiated. These findings are coincident with slowing of motor nerve conduction velocities in the pudendal nerve after SBRT.

Conclusions

This is the first report in which prostatic irradiation was shown to cause morphologic arterial damage that was coincident with altered internal pudendal arterial tone, and in which decreased motor function in the pudendal nerve was attributed to axonal degeneration and loss. Further investigation of the role played by damage to these structures in RI-ED is warranted.}, number={4}, journal={International Journal of Radiation Oncology*Biology*Physics}, publisher={Elsevier BV}, author={Nolan, Michael W. and Marolf, Angela J. and Ehrhart, E.J. and Rao, Sangeeta and Kraft, Susan L. and Engel, Stephanie and Yoshikawa, Hiroto and Golden, Anne E. and Wasserman, Todd H. and LaRue, Susan M.}, year={2015}, month={Mar}, pages={796–806} } @article{yoshikawa_maranon_battaglia_ehrhart_charles_bailey_larue_2014, title={Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase}, volume={14}, ISSN={1476-5810}, url={http://dx.doi.org/10.1111/vco.12117}, DOI={10.1111/vco.12117}, abstractNote={Abstract}, number={4}, journal={Veterinary and Comparative Oncology}, publisher={Wiley}, author={Yoshikawa, H. and Maranon, D. G. and Battaglia, C. L. R. and Ehrhart, E. J. and Charles, J. B. and Bailey, S. M. and LaRue, S. M.}, year={2014}, month={Sep}, pages={371–383} } @article{randall_yoshikawa_kraft_larue_2013, title={A Translational Feline Model of Oral Squamous Cell Carcinoma for Evaluating Tumor Volume Delineation With PET/CT}, volume={3}, ISSN={1879-8500}, url={http://dx.doi.org/10.1016/j.prro.2013.01.099}, DOI={10.1016/j.prro.2013.01.099}, abstractNote={Oral squamous cell carcinoma (SCC) is a locally invasive naturally occurring tumor in cats that responds poorly to radiation therapy. Most cats succumb to failure from local recurrence within 6 months. Feline SCC has comparable histological characteristics, higher pretreatment epidermal growth factor (EGRF) and microvascular density (MDV) values that are associated with a worsened prognosis, similar to human oral SCC. Unlike rodent models, spontaneous tumors in cats are heterogeneous and often hypoxic. The tumors are large enough to obtain adequate biopsy material, and the cats can be imaged and treated with the same modalities as cancer patients. Positron emission tomography- computed tomography (PET/CT) with 18F-fluoro-2-deoxy-D-glucose detects areas with higher glucose metabolism. The goal of the current study was to evaluate the role of 18F-FDG PET for feline radiation therapy patients with oral SCC, as a model of tumor delineation for human disease.}, number={2}, journal={Practical Radiation Oncology}, publisher={Elsevier BV}, author={Randall, E. and Yoshikawa, H. and Kraft, S. and LaRue, S.}, year={2013}, month={Apr}, pages={S29} } @article{yoshikawa_ehrhart_charles_custis_larue_2013, title={Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy}, volume={14}, ISSN={1476-5810}, url={http://dx.doi.org/10.1111/vco.12050}, DOI={10.1111/vco.12050}, abstractNote={Abstract}, number={1}, journal={Veterinary and Comparative Oncology}, publisher={Wiley}, author={Yoshikawa, H. and Ehrhart, E. J. and Charles, J. B. and Custis, J. T. and LaRue, S. M.}, year={2013}, month={Jul}, pages={39–57} } @article{yoshikawa_randall_kraft_larue_2013, title={Comparison between 2-18f-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma}, volume={54}, ISSN={1058-8183}, url={http://dx.doi.org/10.1111/vru.12016}, DOI={10.1111/vru.12016}, abstractNote={Feline oral squamous cell carcinoma is one of the most refractory feline malignancies. Most patients succumb due to failure in local tumor control. 2‐18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography (18F‐FDG PET) is increasingly being used for veterinary oncology staging as it highlights areas with higher glucose metabolism. The goal of the current prospective study was to compare gross tumor volume measurements using 18F‐FDG PET vs. those using computed tomography (CT) for stereotactic radiation therapy planning in cats with oral squamous cell carcinoma. Twelve cats with confirmed oral squamous cell carcinoma underwent pretreatment 18F‐FDG PET/CT. Gross tumor volumes based on contrast‐enhanced CT and 18F‐FDG PET were measured and compared among cats. Mean PET gross tumor volume was significantly smaller than mean CT gross tumor volume in the mandibular/maxillary squamous cell carcinoma group (n = 8, P = 0.002) and for the total number of patients (n = 12, P = 0.006), but not in the lingual/laryngeal group (n = 4, P = 0.57). Mismatch fraction analysis revealed that most of the lingual/laryngeal patients had a large region of high‐18F‐FDG activity outside of the CT gross tumor volume. This mismatch fraction was significantly greater in the lingual/laryngeal group than the mandibular/maxillary group (P = 0.028). The effect of poor spatial resolution of PET imaging was greater when the absolute tumor volume was small. Findings from this study indicated that 18F‐FDG PET warrants further investigation as a supplemental imaging modality in cats with oral squamous cell carcinoma because it detected regions of possible primary tumor that were not detected on CT images.}, number={3}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Yoshikawa, Hiroto and Randall, Elissa K. and Kraft, Susan L. and LaRue, Susan M.}, year={2013}, month={Feb}, pages={307–313} } @article{randall_kraft_yoshikawa_larue_2013, title={Evaluation of 18F-FDG PET/CT as a diagnostic imaging and staging tool for feline oral squamous cell carcinoma}, volume={14}, ISSN={1476-5810}, url={http://dx.doi.org/10.1111/vco.12047}, DOI={10.1111/vco.12047}, abstractNote={Abstract}, number={1}, journal={Veterinary and Comparative Oncology}, publisher={Wiley}, author={Randall, E. K. and Kraft, S. L. and Yoshikawa, H. and LaRue, S. M.}, year={2013}, month={Jun}, pages={28–38} } @article{harmon_yoshikawa_custis_larue_2013, title={Evaluation of canine prostate intrafractional motion using serial cone beam computed tomography imaging}, volume={54}, ISSN={1058-8183}, url={http://dx.doi.org/10.1111/j.1740-8261.2012.01986.x}, DOI={10.1111/j.1740-8261.2012.01986.x}, abstractNote={This study used kilovoltage (kV) cone beam computed tomography (CBCT) imaging to characterize canine intrafractional prostate motion during hypofractionated stereotactic radiotherapy treatment. Serial CBCT images taken just prior to initiating treatment, and at several times during the treatment session, were acquired throughout the course of treatment for canine patients. All patients were immobilized in dorsal recumbency while using an air‐inflated rectal balloon. For each treatment session, rigid registration of intrafraction CBCT images with the interfraction CBCT used for setup verification was performed. Contours of the prostate and urethra were drawn on each CBCT image set and the center of mass for each structure was evaluated as a function of time. A total of seven canine patients was included in the study, resulting in 41 CBCT images collected during a total of 12 treatment sessions. Over 70% of our data were collected for CBCTs taken between 20 and 51 min after final patient setup was complete. The mean intrafraction movement in a single direction for the prostate and urethra was ≤0.14 mm and ≤0.22 mm, respectively. The maximum intrafraction movement for the prostate and urethra was ≤ 1.60 mm and ≤ 2.00 mm, respectively. The maximum variability in intrafraction movement for the prostate and urethra, as defined by two standard deviations, was ≤1.40 mm and ≤1.50 mm, respectively. Minimal intrafraction variability using appropriate patient positioning and rectal balloon, combined with kV CBCT image‐guided radiation therapy tools to account for interfraction changes, permit accurate and precise targeting of structures of interest.}, number={1}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Harmon, Joseph, Jr. and Yoshikawa, Hiroto and Custis, James and LaRue, Susan}, year={2013}, month={Jan}, pages={93–98} } @article{yoshikawa_ehrhart_charles_thamm_larue_2012, title={Immunohistochemical characterization of feline oral squamous cell carcinoma}, volume={73}, ISSN={0002-9645}, url={http://dx.doi.org/10.2460/ajvr.73.11.1801}, DOI={10.2460/ajvr.73.11.1801}, abstractNote={Abstract}, number={11}, journal={American Journal of Veterinary Research}, publisher={American Veterinary Medical Association (AVMA)}, author={Yoshikawa, Hiroto and Ehrhart, E. J. and Charles, Joseph B. and Thamm, Douglas H. and LaRue, Susan M.}, year={2012}, month={Nov}, pages={1801–1806} } @article{yoshikawa_harmon_custis_larue_2012, title={Repeatability of a planning target volume expansion protocol for radiation therapy of regional lymph nodes in canine and feline patients with head tumors}, volume={53}, ISSN={1058-8183}, url={http://dx.doi.org/10.1111/j.1740-8261.2012.01972.x}, DOI={10.1111/j.1740-8261.2012.01972.x}, abstractNote={For canine and feline patients with head tumors, simultaneous irradiation of the primary tumor and mandibular and retropharyngeal lymph nodes (LNs) is often indicated. The purpose of this study was to assess the repeatability of a planning target volume (PTV) expansion protocol for these LNs. Two CT image sets from 44 dogs and 37 cats that underwent radiation therapy for head tumors were compared to determine LN repositioning accuracy and precision; planning‐CT (for radiation therapy planning) and cone‐beam CT (at the time of actual treatment sessions). Eleven percent of dogs and 65% of cats received treatment to their LNs. In dogs, the mandibular LNs were positioned more caudally (P = 0.0002) and the right mandibular and right retropharyngeal LNs were positioned more to the left side of the patient (P = 0.00015 and P = 0.003, respectively). In cats, left mandibular LN was positioned higher (toward roof) than the planning‐CT (P = 0.028). In conclusion, when the patient immobilization devices and bony anatomy matching are used to align the primary head target and these LNs are treated simultaneously, an asymmetrical PTV expansion that ranges 4–9 mm (dogs) and 2–4 mm (cats), depending on the directions of couch movement, should be used to include the LNs within the PTV at least 95% of the time.}, number={6}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Yoshikawa, Hiroto and Harmon, Joseph F. and Custis, James T. and LaRue, Susan M.}, year={2012}, month={Sep}, pages={667–672} } @article{yoshikawa_mayer_2009, title={External beam radiation therapy for canine intracranial meningioma}, volume={50}, number={1}, journal={The Canadian Veterinary Journal / La Revue veterinaire canadienne}, author={Yoshikawa, H. and Mayer, M.N.}, year={2009}, month={Jan}, pages={97–100} } @article{mayer_yoshikawa_sidhu_2009, title={Impact of tissue inhomogeneity on dose distribution in the canine carpal and tarsal regions for cobalt and 6MV photons}, volume={50}, ISSN={1058-8183 1740-8261}, url={http://dx.doi.org/10.1111/j.1740-8261.2009.01543.x}, DOI={10.1111/j.1740-8261.2009.01543.x}, abstractNote={We quantified the effect of tissue inhomogeneity on dose distribution in a canine distal extremity resulting from treatment with cobalt photons and photons from a 6 MV accelerator. Monitor units for a typical distal extremity treatment were calculated by two methods, using equally weighted, parallel‐opposed fields. The first method was a computed tomography (CT)‐based, computerized treatment plan, calculated without inhomogeneity correction. The second method was a manual point dose calculation to the isocenter. A computerized planning system was then used to assess the dose distribution achieved by these two methods when tissue inhomogeneity was taken into account. For cobalt photons, the median percentage of the planning target volume (PTV) that received <95% of the prescribed dose was 4.5% for the CT‐based treatment plan, and 26.2% for the manually calculated plan. For 6 MV photons, the median percentage of the PTV that received <95% of the prescribed dose was <1% for both planning methods. The PTV dose achieved without using inhomogeneity correction for cobalt photons results in potentially significant under dosing of portions of the PTV.}, number={3}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Mayer, Monique N. and Yoshikawa, Hiroto and Sidhu, Narinder}, year={2009}, month={May}, pages={319–322} } @article{mayer_yoshikawa_moriarity_sidhu_2009, title={Use of a petroleum-based bolus for photon radiation therapy of distal extremities in dogs}, volume={50}, ISSN={1058-8183 1740-8261}, url={http://dx.doi.org/10.1111/j.1740-8261.2009.01523.x}, DOI={10.1111/j.1740-8261.2009.01523.x}, abstractNote={While skin sparing is an advantage of megavoltage beams, in certain clinical situations the planning target volume includes the skin surface and a skin sparing effect is not desirable. A tissue equivalent material, termed build up bolus, is used in these situations to provide adequate absorbed dose at the surface of the skin. However, an irregular patient contour can lead to air gaps between the build up bolus and the skin surface, which may result in variability in radiation dose across the target volume. The shape of the canine distal hind extremity is irregular, and commercially available bolus materials do not conform well to this region. The purpose of this study was to assess the dose homogeneity achieved using a petroleum‐based bolus material, in combination with a commercially available sheet bolus, for radiation treatment of the canine tarsus. Repeated setups were performed to mimic daily treatment setups in the clinic setting, and computed tomographic scans were performed after each setup. Dose distribution achieved with a cobalt therapy machine and a 6 MV linear accelerator was assessed using three‐dimensional treatment planning software. The dose to the clinical target volume fell within 95% and 107% of the prescribed dose for both treatment machines, which is considered clinically acceptable by the authors. This petroleum‐based bolus is equivalent to water in its photon attenuation, conforms well to an irregular patient contour, and retains its shape after positioning. Applications to other anatomical sites could be considered.}, number={2}, journal={Veterinary Radiology & Ultrasound}, publisher={Wiley}, author={Mayer, Monique N. and Yoshikawa, Hiroto and Moriarity, Leo and Sidhu, Narinder}, year={2009}, month={Mar}, pages={235–238} } @article{yoshikawa_nakamoto_ozawa_dickinson_2008, title={A Dog with Osteosarcoma which Metastasized to the Eye Months before Metastasis to Other Organs}, volume={70}, ISSN={0916-7250 1347-7439}, url={http://dx.doi.org/10.1292/jvms.70.825}, DOI={10.1292/jvms.70.825}, abstractNote={A 9-year-old male Shih Tzu with osteosarcoma had a forelimb amputation and underwent chemotherapy. During chemotherapy, the right eye was enucleated due to refractory glaucoma, and was diagnosed as anterior uveal malignant melanoma. The dog lived for 4 months after the enucleation without treatment. After the dog died, the mass in the eye was re-evaluated immunohistochemically, and it was diagnosed as metastasis of appendicular osteosarcoma. Metastasis of appendicular osteosarcoma to the anterior chamber is quite rare, and the clinical course which showed clinically detectable metastases to the eye before systemic multi-organ metastases was quite unique.}, number={8}, journal={Journal of Veterinary Medical Science}, publisher={Japanese Society of Veterinary Science}, author={Yoshikawa, Hiroto and Nakamoto, Yuya and Ozawa, Tsuyoshi and Dickinson, Ryan M.}, year={2008}, pages={825–828} } @article{yoshikawa_mayer_linn_dickinson_carr_2008, title={A dog with squamous cell carcinoma in the middle ear}, volume={49}, number={9}, journal={The Canadian veterinary journal / La Revue veterinaire canadienne}, author={Yoshikawa, H. and Mayer, M.N. and Linn, K.A. and Dickinson, R.M. and Carr, A.P.}, year={2008}, month={Sep}, pages={877–879} } @article{mayer_grier_yoshikawa_ringwood_2008, title={Complications associated with the use of vascular access ports in dogs receiving external beam radiation therapy}, volume={233}, ISSN={0003-1488}, url={http://dx.doi.org/10.2460/javma.233.1.96}, DOI={10.2460/javma.233.1.96}, abstractNote={Abstract}, number={1}, journal={Journal of the American Veterinary Medical Association}, publisher={American Veterinary Medical Association (AVMA)}, author={Mayer, Monique N. and Grier, Candace K. and Yoshikawa, Hiroto and Ringwood, P. Brendon}, year={2008}, month={Jul}, pages={96–103} } @article{yoshikawa_watanabe_ozawa_2008, title={Odontoclastic Resorptive Lesions in a Dog}, volume={70}, ISSN={0916-7250 1347-7439}, url={http://dx.doi.org/10.1292/jvms.70.103}, DOI={10.1292/jvms.70.103}, abstractNote={We found odontoclastic resorptive lesions on premolars and molars in a 4- year-old miniature dachshund. The teeth had been extracted because the dentin was resorbed. In some teeth, the roots had been replaced by hard tissue, and so we amputated the crowns and curetted roots and alveolar bone. Histopathological examination revealed that the dentin was resorbed by odontoclasts and was replaced with bony tissue. Ten months later we found resorptive lesions in other teeth, and we treated them along with the first treatment. At the time of writing, since this is the first report of a dog with the same lesion in other teeth after the first treatment, we hope to establish better treatment and prevention methods.}, number={1}, journal={Journal of Veterinary Medical Science}, publisher={Japanese Society of Veterinary Science}, author={Yoshikawa, Hiroto and Watanabe, Kazuhiro and Ozawa, Tsuyoshi}, year={2008}, pages={103–105} }